0001392253-19-000001.txt : 20190516
0001392253-19-000001.hdr.sgml : 20190516
20190516110904
ACCESSION NUMBER: 0001392253-19-000001
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20190516
DATE AS OF CHANGE: 20190516
EFFECTIVENESS DATE: 20190516
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: ENTEGRION INC
CENTRAL INDEX KEY: 0001392253
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-250808
FILM NUMBER: 19830987
BUSINESS ADDRESS:
STREET 1: 1007 SLATER ROAD
STREET 2: SUITE 170
CITY: DURHAM
STATE: NC
ZIP: 27703
BUSINESS PHONE: 919-536-1500
MAIL ADDRESS:
STREET 1: 1007 SLATER ROAD
STREET 2: SUITE 170
CITY: DURHAM
STATE: NC
ZIP: 27703
D/A
1
primary_doc.xml
X0708
D/A
LIVE
0001392253
ENTEGRION INC
1007 SLATER ROAD
SUITE 170
DURHAM
NC
NORTH CAROLINA
27703
919-536-1500
DELAWARE
Hemocellular Therapeutics
None
Corporation
true
Richard
Martin
1007 Slater Road
Suite 170
Durham
NC
NORTH CAROLINA
27703
Executive Officer
Susan
Reyer
1007 Slater Road
Suite 170
Durham
NC
NORTH CAROLINA
27703
Executive Officer
Michael
Galiger
1007 Slater Road
Suite 170
Durham
NC
NORTH CAROLINA
27703
Executive Officer
John
Mowell
1007 Slater Road
Suite 170
Durham
NC
NORTH CAROLINA
27703
Director
Thomas
Edwards
1007 Slater Road
Suite 170
Durham
NC
NORTH CAROLINA
27703
Director
Christopher
Rumana
1007 Slater Road
Suite 170
Durham
NC
NORTH CAROLINA
27703
Director
Patrick
Nash
1007 Slater Road
Suite 170
Durham
NC
NORTH CAROLINA
27703
Director
W
Brian
Gibler
1007 Slater Road
Suite 170
Durham
NC
NORTH CAROLINA
27703
Director
Pierre
Noel
1007 Slater Road
Suite 170
Durham
NC
NORTH CAROLINA
27703
Director
Robert
Capps
1007 Slater Road
Suite 170
Durham
NC
NORTH CAROLINA
27703
Director
J
True
Martin
1007 Slater Road
Suite 170
Durham
NC
NORTH CAROLINA
27703
Director
Richard
Sacher
1007 Slater Road
Suite 170
Durham
NC
NORTH CAROLINA
27703
Director
Biotechnology
Decline to Disclose
- 06b
true
0001392253-17-000002
2015-10-23
true
true
true
true
false
0
8000000
6662328
1337672
false
73
0
0
0
Proceeds will be used for working capital, which will include normal compensation to executive officers.
false
ENTEGRION INC
Susan Reyer
Susan Reyer
Chief Financial Officer
2019-05-15